Shortages ended, the FDA tightened the rules, and telehealth pricing is climbing. Before you overpay or panic, get the honest breakdown of what's actually happening and what your real options are.
Get the free 2026 GLP-1 guide →There are three tiers of GLP-1 access right now. Most people don't realize they're paying premium prices for a layer they may no longer need. Here's the truth, plainly.
The name-brand drug, tested and approved by the FDA. Requires a prescription. The gold standard for oversight — and often $1,000+/month without insurance.
A licensed pharmacy mixes it for you under a prescription. Not the FDA-approved brand, but a prescriber and pharmacy are involved. This is the tier under the most regulatory pressure in 2026 — expect rising prices and tighter eligibility.
The same molecules, sold for research use, backed by independent third-party lab testing (a Certificate of Analysis) so purity and dosage are transparent. No clinic layer, no prescription — which is why it's a fraction of the price. The trade-off is yours to weigh, and we believe in helping you weigh it honestly.
We're the credible, accessible option — built for everyday people, not biohackers.
What the FDA changes mean for you, the real difference between your options, and how to read a COA so you never get fooled by a fake. Plus a launch discount for your first order.
No spam. Unsubscribe anytime. We'll email the guide + your discount code.